Abstract Details

Title Employability, Work Difficulties and Factors Impacting Chronic Migraine Patients of Hawaii: Results of a Quality Improvement Survey

Topic Headache

Presentation(s) P17 - Poster Session 17 (11:45 AM-12:45 PM)

Poster/Presentation
Number 15-005

Objective

Investigate the relationship between work-related difficulties and key factors that negatively impact employability and quality of life (QoL) for patients with intractable vs. non-intractable chronic migraines.

Background Chronic intractable migraines have a significant impact on patients’ daily lives. Many tools measure migraine impact on daily functioning, but triggers and work-related difficulties are often inadequately addressed. The Headache Impact Test (HIT-6) and HEADWORK questionnaire capture a variety of difficulties and factors that may impact patients with migraine at work and home.

Design/Methods A single-centered, retrospective chart review was conducted to identify patients diagnosed with migraine and seen between April and June 2021. Patient demographics, past medical history, and medication trials for abortive and preventative migraine treatments were collected. Phone surveys were performed using the HIT-6 and HEADWORK questionnaire. Employed patients were categorized using the Standard Occupational Classification system for statistical analysis. Nonparametric bivariate analyses with an alpha < 0.05 were utilized.

Results Of 654 patients recruited for phone calls, 182 (28%) completed the survey and were further analyzed. 64.8% were diagnosed with intractable migraines and 35.2% with non-intractable migraines. Intractable migraine patients had an odds ratio of 0.51 for being employed (p=0.05). Additionally, intractable migraine patients had an odds ratio of 3.70 for encountering difficulties dealing with work problems. 56.3% of patients have tried five or more migraine medications with 37.5% of these patients having a positive HIT6 score and 70% having intractable migraines.

Conclusions The findings suggest that intractable migraine patients are half as likely to be employed compared to non-intractable migraine patients, highlighting the incapacitating nature of these migraines. This was also reflected in higher HIT-6 scores and corresponding decreased QoL. The multifactorial management of these patients with potentially debilitating migraines may necessitate a biopsychosocial approach for improved quality of care and life.

Authors/Disclosures
Michelle Stafford PRESENTER	Miss Stafford has nothing to disclose.
	No disclosure on file
Rachel Gorenflo	Rachel Gorenflo has nothing to disclose.
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
Vimala S. Vajjala, MBBS (Banner University Medical Center)	Dr. Vajjala has nothing to disclose.
Enrique Carrazana (Neurelis, Inc.)	Enrique Carrazana has received personal compensation for serving as an employee of Neurelis. Enrique Carrazana has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Hawaii-Biotech, CND Life Sciences, Apex Labs. Enrique Carrazana has stock in Neurelis, CND, Apex.
Kore K. Liow, MD, FACP (University of Hawaii, John Burns School of Medicine)	The institution of Dr. Liow has received research support from UCB. The institution of Dr. Liow has received research support from Livanova. The institution of Dr. Liow has received research support from Biogen. The institution of Dr. Liow has received research support from Novartis. The institution of Dr. Liow has received research support from Eisai. The institution of Dr. Liow has received research support from Engage Therapeutics. The institution of Dr. Liow has received research support from SK Lifescience. The institution of Dr. Liow has received research support from Cerevel. The institution of Dr. Liow has received research support from Xenon. The institution of Dr. Liow has received research support from NeuroDerm. The institution of Dr. Liow has received research support from Avanir. The institution of Dr. Liow has received research support from Annovis. The institution of Dr. Liow has received research support from Acadia. The institution of Dr. Liow has received research support from Prothena. The institution of Dr. Liow has received research support from SAGE. The institution of Dr. Liow has received research support from Annovis. The institution of Dr. Liow has received research support from Cyclerion.

��ɫ��

��ɫ��